Keywords: Merck Serono, Nordic Bioscience, Sprifermin, Osteoporosis of kneww, Merck KGaA, Research collaboration

Merck Serono collaborates with Nordic Bioscience for sprifermin in osteoarthritis

Article | 18 March 2013

Print This

German drug and chemical major Merck KGaA (MRK: DE) says its Merck Serono division has entered into a strategic alliance ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in